by J Carter | Aug 8, 2026 | Uncategorized
These studies show how different neurological conditions may share a common opportunity: targeting biological processes that drive nerve damage. In Parkinson’s disease, a vaccine trained the immune system to recognize harmful α-synuclein aggregates and delayed...
